Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Berchem

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|December 3, 2014
[Editorial]Guy Berchem
Oncoimmunology|December 5, 2022
A role for EMT in CD73 regulation in breast cancerMeriem Hasmim, Guy Berchem, Bassam Janji
Frontiers in Immunology|June 21, 2018
Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor ImmunityBassam Janji, Guy Berchem, Salem Chouaib
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|June 12, 2009
A case of acute haemolysis with 2 different multi target thyrosine kinase inhibitors in a patient with renal cancerGuy Berchem, Sigrid Dewilde, Philippe Mahassen
Oncotarget|February 16, 2017
Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progressionMassimo Giuliani, Bassam Janji, Guy Berchem
Autophagy|January 26, 2018
Targeting autophagy blocks melanoma growth by bringing natural killer cells to the tumor battlefieldMuhammad Zaeem Noman, Guy Berchem, Bassam Janji
Hematology (Amsterdam, Netherlands)|March 7, 2023
Real-world experience with isatuximab in the treatment of relapsed-refractory multiple myeloma: a case series from the Grand Duchy of LuxembourgSigrid De Wilde, Laurent Plawny, Guy Berchem
Molecular Oncology|December 11, 2024
Impact of molecular diagnostics and targeted cancer therapy on patient outcomes (MODIFY): a retrospective study of the implementation of precision oncologyMichaël Dang, Anna Schritz, Nikolai Goncharenko, et al.
Clinical Nuclear Medicine|July 9, 2019
Recovery of Renal Function Under PSMA Mediated Radioligand Therapy of Advanced Metastasized Castration Resistant Prostate CancerMartin Ries, Fadi Khreish, Guy Berchem, et al.
Clinical Chemistry and Laboratory Medicine|May 16, 2003
Comparison of standard PCR and the LightCycler technique to determine the thrombophilic mutations: an efficiency and cost studyBrigitte Schroell-Metzger, Mario Dicato, Manon Bosseler, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|December 3, 2014
[Editorial]Guy Berchem
Oncoimmunology|December 5, 2022
A role for EMT in CD73 regulation in breast cancerMeriem Hasmim, Guy Berchem, Bassam Janji
Frontiers in Immunology|June 21, 2018
Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor ImmunityBassam Janji, Guy Berchem, Salem Chouaib
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|June 12, 2009
A case of acute haemolysis with 2 different multi target thyrosine kinase inhibitors in a patient with renal cancerGuy Berchem, Sigrid Dewilde, Philippe Mahassen
Oncotarget|February 16, 2017
Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progressionMassimo Giuliani, Bassam Janji, Guy Berchem
Autophagy|January 26, 2018
Targeting autophagy blocks melanoma growth by bringing natural killer cells to the tumor battlefieldMuhammad Zaeem Noman, Guy Berchem, Bassam Janji
Hematology (Amsterdam, Netherlands)|March 7, 2023
Real-world experience with isatuximab in the treatment of relapsed-refractory multiple myeloma: a case series from the Grand Duchy of LuxembourgSigrid De Wilde, Laurent Plawny, Guy Berchem
Molecular Oncology|December 11, 2024
Impact of molecular diagnostics and targeted cancer therapy on patient outcomes (MODIFY): a retrospective study of the implementation of precision oncologyMichaël Dang, Anna Schritz, Nikolai Goncharenko, et al.
Clinical Nuclear Medicine|July 9, 2019
Recovery of Renal Function Under PSMA Mediated Radioligand Therapy of Advanced Metastasized Castration Resistant Prostate CancerMartin Ries, Fadi Khreish, Guy Berchem, et al.
Clinical Chemistry and Laboratory Medicine|May 16, 2003
Comparison of standard PCR and the LightCycler technique to determine the thrombophilic mutations: an efficiency and cost studyBrigitte Schroell-Metzger, Mario Dicato, Manon Bosseler, et al.
Pageof 10